Yeshan H. Chen

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Zuska's disease of the breast: a clinicopathological analysis of 315 cases

Zuska's disease of the breast: a clinicopathological analysis of 315 cases

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: September 07, 2026

Boosting mRNA cancer vaccine efficacy via targeting Irg1 on macrophages in lymph nodes.

Boosting mRNA cancer vaccine efficacy via targeting Irg1 on macrophages in lymph nodes.

Journal: Theranostics

Published: January 11, 2025

Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial.

Sintilimab combined with bevacizumab in relapsed or persistent ovarian clear cell carcinoma (INOVA): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: March 13, 2024

Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review.

Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review.

Journal: Frontiers in immunology

Published: October 07, 2023

ROS impairs tumor vasculature normalization through an endocytosis effect of caveolae on extracellular SPARC.

ROS impairs tumor vasculature normalization through an endocytosis effect of caveolae on extracellular SPARC.

Journal: Cancer cell international

Published: March 30, 2023

Feasibility and long-term outcomes of post-chemotherapy-based consolidation radiotherapy in extensive stage small-cell lung cancer.

Feasibility and long-term outcomes of post-chemotherapy-based consolidation radiotherapy in extensive stage small-cell lung cancer.

Journal: Journal of the National Cancer Center

Published: December 27, 2022

Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer.

Case report: A successful re-challenge report of GLS-010 (Zimberelimab), a novel fully humanized mAb to PD-1, in a case of recurrent endometrial cancer.

Journal: Frontiers in immunology

Published: July 06, 2022

Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19.

Durable tracking anti-SARS-CoV-2 antibodies in cancer patients recovered from COVID-19.

Journal: Scientific reports

Published: April 15, 2021

Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak.

Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak.

Journal: Gynecologic oncology

Published: April 23, 2020

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.

Journal: Cancer discovery

Published: April 02, 2020

Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.

Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 30, 2020

PAK6 promotes cervical cancer progression through activation of the Wnt/β-catenin signaling pathway.

PAK6 promotes cervical cancer progression through activation of the Wnt/β-catenin signaling pathway.

Journal: Oncology letters

Published: February 09, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026